MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ANIX — Anixa Biosciences, Inc.
NasdaqAnixa Biosciences, Inc.
$2.95
+0.18(+6.50%)
- O
- 2.83
- H
- 2.95
- L
- 2.77
- V
- 426.18K
⏱️ End-of-day dataAs of Oct 2, 2026
ANIX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2025 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 |
| Cash And Cash Equivalents | $1.48M | $1.55M | $1.24M | $1.50M | $1.91M | $1.05M |
| Other Short Term Investments | $12.21M | $12.65M | $13.93M | $14.53M | $13.69M | $16.20M |
| Accounts Receivable | 56,000.00 | N/A | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 950,000.00 | 848,000.00 | 713,000.00 | $1.42M | $1.17M | $1.43M |
| Total Current Assets | $14.69M | $15.05M | $15.89M | $17.45M | $16.77M | $18.69M |
| Properties | 173,000.00 | 183,000.00 | 193,000.00 | 202,000.00 | 0.00 | 0.00 |
| Total Non Current Assets | 173,000.00 | 183,000.00 | 193,000.00 | 202,000.00 | 211,000.00 | 220,000.00 |
| Total Assets | $14.87M | $15.23M | $16.08M | $17.65M | $16.98M | $18.91M |
| Accounts Payable | 252,000.00 | 148,000.00 | 165,000.00 | 276,000.00 | 284,000.00 | 600,000.00 |
| Accrued Expenses | $1.21M | $1.05M | $1.76M | $1.75M | $1.57M | $1.36M |
| Short Term Debt | 44,000.00 | 42,000.00 | 41,000.00 | 39,000.00 | 37,000.00 | 36,000.00 |
| Total Current Liabilities | $1.50M | $1.24M | $1.97M | $2.07M | $1.89M | $2.00M |
| Long Term Debt | 140,000.00 | 151,000.00 | 163,000.00 | 174,000.00 | 184,000.00 | 194,000.00 |
| Total Non Current Liabilities | 140,000.00 | 151,000.00 | 163,000.00 | 174,000.00 | 184,000.00 | 194,000.00 |
| Total Liabilities | $1.64M | $1.39M | $2.13M | $2.24M | $2.07M | $2.19M |
| Common Stock | 339,000.00 | 335,000.00 | 330,000.00 | 328,000.00 | 322,000.00 | 322,000.00 |
| Retained Earnings | $-25.68M | $-25.42M | $-25.17M | $-24.90M | $-24.67M | $-24.39M |
| Total Shareholders Equity | $13.22M | $13.85M | $13.95M | $15.41M | $14.91M | $16.71M |
| Additional Paid In Capital | $27.09M | $26.90M | $26.65M | $26.52M | $26.25M | $26.15M |
| Minority Interest | $-1.25M | $-1.23M | $-1.21M | $-1.18M | $-1.16M | $-1.14M |
| Leases | N/A | N/A | 193,000.00 | 202,000.00 | 211,000.00 | N/A |
| Treasury Stock | N/A | N/A | 0.00 | 0.00 | 0.00 | 6,000.00 |